Cancer discovery news
Our researchers are making the discoveries that defeat cancer. Read the latest findings from our world-leading research.
Visit our main news hub to read about news on new funding, our fundraising activities and much more. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
New centre targets ‘undruggable’ cancers after major donation
The centre will focus on ‘targeted protein degradation’ – one of the hottest and most promising areas in drug discovery. Scientists aim to hijack normal process of protein destruction to wipe out cancer proteins that traditional targeted drugs cannot block.
Study shows more women with invasive lobular breast cancer should qualify for tailored clinical trials
A new study led by scientists at The Institute of Cancer Research, London, has changed our understanding of invasive lobular breast cancer – and could increase the number of patients who access new treatments via lobular breast cancer specific clinical trials.
Test can personalise use of immunotherapy and chemotherapy for head and neck cancer
Matching cancer patients to treatment based on their levels of a key immune protein may allow doctors to select those who would benefit most from the combination of immunotherapy and chemotherapy, researchers report.
ICR welcomes FDA approval of ‘search and destroy’ treatment
The Institute of Cancer Research, London, strongly welcomes the news that 177Lu-PSMA-617, a potent radioactive medicine that searches for tumour cells to deliver a radioactive payload, has been approved by the US Food and Drug Administration (FDA) for treating some advanced prostate cancers.
Longer course of hormonal therapy before surgery for breast cancer has greater impact on tumour growth
Treating some women with higher risk breast cancer with a longer course of hormonal therapy before surgery led to more changes in the genetic makeup of their tumours, some of which were associated with better survival outcomes.
ICR Discovery Club showcases how we take new drugs to cancer patients
Members of the Discovery Club gathered at the Royal Society of Chemistry to hear how our scientists are moving new cancer drugs into the clinic.
'Man Van' launched to speed up early diagnosis of prostate cancer and improve healthcare access
The 'Man Van', an innovative new outreach programme, has been launched today to provide free health checks for men and boost early diagnosis of prostate and other urological cancers.
Spinal fluid analysis could speed up diagnosis of breast cancer spread
Analysing cancer DNA in spinal fluid could speed up and improve the diagnosis of breast cancer which has spread to the brain and spinal cord, according to a new pilot study.
Cancer Research UK renew support for Convergence Science Centre
Renewed Cancer Research UK funding for Convergence Science Centre at the ICR and Imperial will build on existing partnership by uniting cancer researchers with engineers and physical scientists to tackle cancer’s toughest challenges.
ESMO Virtual Plenary 2022: Major trial shows targeted drug improves survival in early-stage breast cancer with inherited BRCA1 or BRCA2 mutation
The ICR strongly welcomes new findings that the targeted drug olaparib improves survival in women with high-risk, early-stage breast cancer who have inherited faults in their BRCA1 or BRCA2 genes.
#BreakTheBias: Scientists showcase their lives outside the lab
What do scientists look like? This International Women’s Day, we are introducing some of our researchers to help #BreakTheBias, and showcasing the full lives and passions of our scientists outside the lab – from dancing and baking to running or playing an instrument.
New home for innovative life-science companies opens at The London Cancer Hub
A new incubator and collaboration space for innovative life-science companies whose work is relevant to cancer is opening its doors at The London Cancer Hub in Sutton, south London.